Trans-scleral Surgery

The approach uses the sclera as the entry surface rather than passing through the cornea or lens. A controlled incision or needle-based route can then reach the choroid, retina, vitreous, or suprachoroidal space. This anatomical pathway supports targeted intervention while limiting disruption to structures that are not the intended treatment or research target.

The selected route depends on the tissue or anatomical space that must be reached and on the type of intervention being performed. Incisions provide controlled access through the sclera, whereas needle-based entry can support delivery into selected ocular compartments. These options allow the procedure to be adapted for retinal repair, therapeutic delivery, or targeted laser work.

They place therapeutics near or within regions containing retinal neural tissue, allowing more localized intervention than a nonspecific ocular approach. Subretinal delivery reaches the space beneath the retina, while suprachoroidal access targets the space between the sclera and choroid. In neuroscience research, these routes help investigate localized treatment effects and retinal function.

Its principal distinction is the access pathway: the sclera provides a posterior route toward the choroid, retina, vitreous, or suprachoroidal space. By avoiding direct passage through the cornea and lens, the approach can focus intervention on posterior ocular tissues. This makes it particularly relevant when the experimental or therapeutic target lies within the retina or behind it.

The procedure is designed to create precise access through the sclera, reach the intended ocular compartment, and deliver or perform the planned intervention while limiting unnecessary disruption. Depending on the study, the objective may be therapeutic placement in the subretinal or suprachoroidal space, retinal repair, or a targeted laser procedure. The access route is matched to that objective.

Researchers may use it when an experiment requires localized access to retinal tissue or nearby ocular spaces. Applications include testing therapeutic delivery, developing retinal repair strategies, creating experimental models, and evaluating targeted laser interventions. Because the route can reach posterior ocular structures, it supports studies focused on retinal neural tissue and vision-threatening retinal disorders.

The approach can support localized drug delivery, retinal repair, and targeted laser procedures, depending on the intervention. It also enables experimental models in which researchers examine responses within or behind the retina. These capabilities are relevant to investigating vision-threatening retinal disorders and to evaluating whether a treatment can act near its intended neural tissue.

Scleral access provides a direct route toward posterior structures without requiring the intervention to cross the cornea and lens. This can help position a therapeutic, repair procedure, or laser treatment closer to the choroid, retina, vitreous, or suprachoroidal space. In retinal neuroscience, that localization can improve experimental control and clarify effects on neural tissue.